News

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...
Shares of Inspire Medical SystemsINSP crashed Tuesday after the maker of implantable sleep apnea devices called out GLP-1 ...
Eli Lilly and Co.'s Kenosha County project will be eligible for the largest tax break ever under the state of Wisconsin's ...
As Eli Lilly rolls ahead with a $27 billion investment to prop up four new manufacturing facilities in the U.S, the company ...
At least 26 patients have filed lawsuits in Marion County against Eli Lilly and Co. over its marketing of GLP-1 drugs ...
Hyderabad: Ina major boost to Telangana’s life sciences and innovation ecosystem, global pharmaceutical giant Eli Lilly ...
Hyderabad: Pharma giant Eli Lilly and Company (India) opened its new technology and innovation centre in Hyderabad's Hitech ...
The Wisconsin Economic Development Corp. is offering pharmaceutical giant Eli Lilly up to $100 million in tax credits to ...
Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...
Eli Lilly's growth is fueled by GLP-1 blockbusters and a solid pipeline, yet high valuations and reliance on key drugs ...
Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, ...
Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...